Early Progression and Immune Reconstitution Inflammatory Syndrome During Treatment of Mild-To-Moderate Kaposi Sarcoma in Sub-Saharan Africa and South America: Incidence, Long-Term Outcomes, and Effects of Early Chemotherapy
Mulinda Nyirenda(University of Malawi), Thomas Campbell(University of Colorado Anschutz Medical Campus), Stephanie Caruso(Frontier Science & Technology Research Foundation, Inc.), Catherine Godfrey(United States Department of State), Margaret Borok(University of Zimbabwe), Wadzanai Samaneka(University of Zimbabwe), Dirk P. Dittmer(University of North Carolina at Chapel Hill), Susan E. Krown(Memorial Sloan Kettering Cancer Center), Brenda Hoagland(Fundação Oswaldo Cruz), Oto Martinez-Maza(University of California, Los Angeles), Triin Umbleja(Harvard University), McNeil Ngongondo, Noluthando Mwelase(University of the Witwatersrand), Rosie Mngqibisa, Mina C. Hosseinipour, Minhee Kang(Cancer Research And Biostatistics)
Cited by 15
Related Papers
Kaposi sarcoma
|Nature Reviews Disease Primers|2019|707
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
|New England Journal of Medicine|2021|661
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
|New England Journal of Medicine|2021|548
Alterations in the Gut Microbiota Associated with HIV-1 Infection
|Cell Host & Microbe|2013|508